Evaluation of the Efficacy and Safety of VX-814 in Subjects With the PiZZ Genotype
Clinical trial NCT04167345 · TERMINATED
Trial details
- NCT number
- NCT04167345
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-13
- Primary completion
- 2020-11-14
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.